MX2009013574A - Formas de dosificacion solidas o semisolidas de liberacion modificada. - Google Patents

Formas de dosificacion solidas o semisolidas de liberacion modificada.

Info

Publication number
MX2009013574A
MX2009013574A MX2009013574A MX2009013574A MX2009013574A MX 2009013574 A MX2009013574 A MX 2009013574A MX 2009013574 A MX2009013574 A MX 2009013574A MX 2009013574 A MX2009013574 A MX 2009013574A MX 2009013574 A MX2009013574 A MX 2009013574A
Authority
MX
Mexico
Prior art keywords
solid
semi
dosage forms
modified release
along
Prior art date
Application number
MX2009013574A
Other languages
English (en)
Inventor
Der-Yang Lee
Jen-Chi Chen
Robert Shen
Vincent Chen
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of MX2009013574A publication Critical patent/MX2009013574A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Abstract

Se proporcionan una forma de dosificación farmacéutica sólida o semisólida que comprende fármacos antiinflamatorios no esteroides, en particular, derivados del ácido propiónico tales como el ibuprofeno, junto con un segundo ingrediente activo que tiene una duración de concentración en plasma terapéuticamente eficaz más breve, tal como la fenilefrina, y métodos para administrarla; este método proporciona un efecto terapéutico mejorado, en particular el alivio del dolor junto con el alivio descongestivo a lo largo de periodos prolongados.
MX2009013574A 2007-06-12 2008-06-09 Formas de dosificacion solidas o semisolidas de liberacion modificada. MX2009013574A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/761,698 US9833510B2 (en) 2007-06-12 2007-06-12 Modified release solid or semi-solid dosage forms
PCT/US2008/066265 WO2008157103A2 (en) 2007-06-12 2008-06-09 Modified release solid or semi-solid dosage forms

Publications (1)

Publication Number Publication Date
MX2009013574A true MX2009013574A (es) 2010-01-25

Family

ID=39960610

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009013574A MX2009013574A (es) 2007-06-12 2008-06-09 Formas de dosificacion solidas o semisolidas de liberacion modificada.

Country Status (11)

Country Link
US (1) US9833510B2 (es)
EP (1) EP2180886B1 (es)
CN (1) CN101677967A (es)
AU (1) AU2008266262A1 (es)
BR (1) BRPI0813449A2 (es)
CA (1) CA2687722A1 (es)
ES (1) ES2607796T3 (es)
MX (1) MX2009013574A (es)
NZ (1) NZ581304A (es)
RU (1) RU2471480C2 (es)
WO (1) WO2008157103A2 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1811979T3 (pl) * 2004-09-27 2009-04-30 Sigmoid Pharma Ltd Mikrokapsułki zawierające metyloksantynę i kortykosteroid
EP2380564B1 (en) 2007-04-04 2014-10-22 Sigmoid Pharma Limited An oral pharmaceutical composition
CA2685118C (en) 2007-04-26 2016-11-01 Sigmoid Pharma Limited Manufacture of multiple minicapsules
JP2010526054A (ja) * 2007-05-01 2010-07-29 シグモイド・ファーマ・リミテッド 併用医薬組成物
DK2471518T3 (en) 2009-05-18 2017-12-04 Sigmoid Pharma Ltd COMPOSITION INCLUDING OIL DROPS
US9878036B2 (en) 2009-08-12 2018-01-30 Sigmoid Pharma Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
US8187617B2 (en) * 2009-09-11 2012-05-29 William Wayne Howard Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments
CN102985078B (zh) * 2010-04-07 2016-04-06 奥荷马公司 用于动物的口服递送的微粒
USPP22279P2 (en) 2010-09-02 2011-11-29 Floranova Service Corp Ipomoea plant named ‘IPOSGLGRE’
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
US20130004563A1 (en) * 2011-06-07 2013-01-03 Shah Syed Multiparticulate s-adenosylmethionine compositions and related methods
CN110075310A (zh) 2011-12-20 2019-08-02 维奥姆治疗有限公司 用于治疗真菌感染的局部油组合物
AU2013240289B2 (en) 2012-03-29 2018-01-25 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
EP2968187A4 (en) 2013-03-14 2016-08-17 Therabiome Llc TARGETED ADMINISTRATION OF PROBIOTIC ORGANISMS AND / OR THERAPEUTIC AGENTS IN THE GASTROINTESTINAL TRACT
US20140271893A1 (en) * 2013-03-15 2014-09-18 Mcneil-Ppc, Inc. Coated phenylephrine particles and use thereof in pharmaceutical formulations
BR112015030501A2 (pt) * 2013-06-04 2017-07-25 Vyome Biosciences Pvt Ltd partículas revestidas e composições que compreendem as mesmas
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
MX2016009898A (es) 2014-01-29 2017-01-23 Vyome Biosciences Pvt Ltd Tratamientos para acne resistente.
WO2015152433A1 (en) * 2014-03-31 2015-10-08 Hanmi Pharm. Co., Ltd. Amorphous solid dispersion comprising paclitaxel, tablet comprising the same, and method for preparing the same
US20160081943A1 (en) * 2014-09-19 2016-03-24 The Procter & Gamble Company Process For Making A Core With An Active Coating
EP3193845A1 (en) * 2014-09-19 2017-07-26 The Procter and Gamble Company Pulsed release phenylephrine dosage forms
ES2858517T3 (es) 2014-11-07 2021-09-30 Sublimity Therapeutics Ltd Composiciones que comprenden ciclosporina
GB201420300D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Tablet
GB201420306D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Compositions
GB201420311D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Pharmaceutical processing
MA41152A (fr) 2014-12-12 2017-10-17 Johnson & Johnson Consumer Inc Procédé de fabrication de particules de résinate de phényléphrine ; particules de résinate de phényléphrine et utilisation des particules de résinate de phényléphrine dans des formulations pharmaceutiques
KR101852922B1 (ko) * 2016-08-25 2018-04-30 (주)씨앤엠텍 락타아제를 포함하는 이중 미세캡슐, 이의 제조방법 및 용도
BR112019005224A2 (pt) * 2016-09-26 2019-06-11 Procter & Gamble forma de dosagem para alívio prolongado
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion
CN107469068B (zh) * 2017-08-04 2021-06-22 南京碧迪可医药科技有限公司 一种硫肽环素的药物组合物
JP2022521316A (ja) 2019-02-22 2022-04-06 キャタレント・ユーケー・スウィンドン・ザイディス・リミテッド 水性懸濁液中の無溶媒混合プロセスによって産生される機能的にコーティングされたａｐｉ粒子の保存
KR20210130722A (ko) * 2019-02-22 2021-11-01 카탈렌트 유.케이. 스윈던 지디스 리미티드 의약품의 붕해 시간을 안정화하기 위한 저장 동안 약물 입자 코팅 물질의 응집 최소화
MX2021009679A (es) 2019-02-22 2021-09-10 Catalent Uk Swindon Zydis Ltd Minimizacion de aglomeracion, aireacion y conservacion del revestimiento de composiciones farmaceuticas que comprenden ibuprofeno.
CN113876731B (zh) * 2021-10-29 2023-10-13 山东则正医药技术有限公司 一种含布洛肾素那敏的药物组合物及制备方法
CN116370428A (zh) * 2023-04-28 2023-07-04 济南市中西医结合医院 一种布洛芬缓释片、制备方法及用途

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
US3185626A (en) * 1963-03-06 1965-05-25 Sterling Drug Inc Tablet coating method
US3485719A (en) * 1967-10-13 1969-12-23 Us Agriculture Continuous process for producing xanthomonas heteropolysaccharide
GB1497044A (en) * 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
US4543370A (en) * 1979-11-29 1985-09-24 Colorcon, Inc. Dry edible film coating composition, method and coating form
US4683256A (en) * 1980-11-06 1987-07-28 Colorcon, Inc. Dry edible film coating composition, method and coating form
GB8317696D0 (en) 1983-06-29 1983-08-03 Shell Int Research Preparing xanthomonas heteroplysaccharide
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4847077A (en) * 1984-07-18 1989-07-11 Pennwalt Corporation Controlled release pharmaceutical preparations
US4643894A (en) * 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
US4828841A (en) * 1984-07-24 1989-05-09 Colorcon, Inc. Maltodextrin coating
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4788055A (en) 1985-12-09 1988-11-29 Ciba-Geigy Corporation Resinate sustained release dextromethorphan composition
US4873231A (en) * 1986-04-08 1989-10-10 Smith Walton J Decreasing the toxicity of an ibuprofen salt
US4802924A (en) * 1986-06-19 1989-02-07 Colorcon, Inc. Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4906478A (en) * 1988-12-12 1990-03-06 Valentine Enterprises, Inc. Simethicone/calcium silicate composition
US4975465A (en) * 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
NZ233403A (en) * 1989-04-28 1992-09-25 Mcneil Ppc Inc Simulated capsule-like medicament
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5275822A (en) * 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
US5183829A (en) * 1991-09-27 1993-02-02 Applied Analytical Industries, Inc. Oral liquid compositions of non-steroidal anti-inflammatory drugs
KR940703886A (ko) * 1992-01-17 1994-12-12 토머스 디. 뵈닝 셀룰로오스 중합체 및 락토오스 기재 필름 코팅 조성물 및 필름 코팅(Film Coatings and Film Coating Compositions Based on Cellulosic Polymers and Lactose)
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
JP3207494B2 (ja) 1992-04-02 2001-09-10 ロート製薬株式会社 水性懸濁製剤
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
RU2134105C1 (ru) * 1993-06-18 1999-08-10 Смитклайн Бичам Корпорейшн Мягкая желатиновая капсула
IT1264855B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
US5439072A (en) * 1994-03-17 1995-08-08 Jenkins, Jr.; Joseph R. Modular ladder system
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
AU736308B2 (en) * 1996-12-20 2001-07-26 Warner-Lambert Company Llc Antitussive drugs delivered by ion exchange resins
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
SI0931543T1 (en) * 1997-12-19 2002-10-31 Merck Patent Gmbh Multilayered tablet comprising probiotic microorganisms such as lactobacilli or bifidobacteria
US5997905A (en) * 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles
RU2236847C2 (ru) * 1998-11-02 2004-09-27 Илан Корпорейшн, Плк. Композиции в виде множества частиц с модифицированным высвобождением
US6274162B1 (en) * 2000-01-14 2001-08-14 Bpsi Holdings, Inc. Elegant film coating system
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US6814978B2 (en) * 2000-12-29 2004-11-09 Mcneil-Ppc, Inc. Process for preparing a soft tablet
CA2685214C (en) 2001-02-08 2013-01-22 Andrx Pharmaceuticals, Inc. Improved controlled release oral dosage form
EP1429728A1 (en) * 2001-08-29 2004-06-23 SRL Technologies, Inc. Sustained release preparations
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
WO2003101431A1 (en) * 2002-06-04 2003-12-11 J.B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical composition for controlled drug delivery system
CA2510465A1 (en) * 2002-12-18 2004-07-08 Pain Therapeutics Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
US20040253311A1 (en) 2002-12-18 2004-12-16 Roger Berlin Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
EP1675576A1 (en) * 2003-10-03 2006-07-05 LifeCycle Pharma A/S A method for preparing modified release pharmaceutical compositions
US9492541B2 (en) * 2004-09-14 2016-11-15 Sovereign Pharmaceuticals, Llc Phenylepherine containing dosage form
US20050191349A1 (en) * 2003-12-31 2005-09-01 Garth Boehm Galantamine formulations
US20050249802A1 (en) * 2004-05-06 2005-11-10 The Procter & Gamble Company Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
EP1765305A4 (en) * 2004-07-09 2008-06-04 Drugtech Corp REGULATED PHASE COMPOSITION TECHNOLOGY USED AS ENHANCED MEDICATION PROTECTION METHOD
WO2006022996A2 (en) * 2004-08-04 2006-03-02 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
WO2007143158A2 (en) * 2006-06-01 2007-12-13 Schering-Plough Healthcare Products, Inc. Sustained release pharmaceutical formulation comprising phenylephrine
RU2009123445A (ru) * 2006-11-21 2010-12-27 МакНЕЙЛ-ППС, ИНК. (US) Анальгетические суспензии модифицированного высвобождения
US20150342882A1 (en) 2012-06-28 2015-12-03 Johnson & Johnson Consumer Inc. Methods of treatment using cadotril compositions

Also Published As

Publication number Publication date
CN101677967A (zh) 2010-03-24
RU2471480C2 (ru) 2013-01-10
WO2008157103A2 (en) 2008-12-24
NZ581304A (en) 2012-01-12
CA2687722A1 (en) 2008-12-24
US9833510B2 (en) 2017-12-05
EP2180886B1 (en) 2016-09-21
RU2010100815A (ru) 2011-07-20
AU2008266262A1 (en) 2008-12-24
EP2180886A2 (en) 2010-05-05
BRPI0813449A2 (pt) 2014-12-23
US20080311201A1 (en) 2008-12-18
ES2607796T3 (es) 2017-04-04
WO2008157103A3 (en) 2009-05-22

Similar Documents

Publication Publication Date Title
MX2009013574A (es) Formas de dosificacion solidas o semisolidas de liberacion modificada.
MX2009005339A (es) Suspensiones analgesicas de liberacion modificada.
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
MX2009006007A (es) Profarmacos y metodos para hacer y usar los mismos.
WO2008027350A3 (en) Acetaminophen pharmaceutical compositions
WO2008131057A3 (en) Sustained release formulations of opioid and nonopioid analgesics
WO2007098479A3 (en) Localized insulin delivery for bone healing
WO2008022256A3 (en) Methods and compositions for preventing or treating age-related diseases
MX2009010000A (es) Dispositivo para el suministro de farmaco.
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
MX2015005798A (es) Terapia de combinacion.
WO2008011426A3 (en) Methods and medicaments for administration of ibuprofen
AR124500A2 (es) Aumento de la biodisponibilidad de droga en terapia naltrexona
WO2011029948A3 (de) Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff davon
MX2009004017A (es) Usos de los compuestos carboxi-amido triazol y sus sales.
WO2008025790A3 (en) Use of opioid formulations in needle-less drug delivery devices
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação
AR073435A1 (es) Composicion farmaceutica de liberacion modificada de un musculo relajante y un aine
WO2007143185A3 (en) Transdermal treatment of tendinopathy using glyceryl trinitrite
WO2008051527A3 (en) Sustained release of agents for localized pain management
MX341660B (es) Agonista del receptor de ghrelina para el tratamiento de caquexia.
BR112012014107B8 (pt) sistema terapêutico transdérmico (tts) e processo de produção de tts
NO20054646L (no) Doseringskur for ikke-steroidalt anti-inflammatorisk legemiddel
WO2007103190A3 (en) Transdermal treatment of tendinop athy using no donor